This content is from:365亚博 This Hedge Fund Is ‘Reasonably Confident’ a Covid-19 Vaccine Will Be Approved This Year MKP Capital has also calculated the odds of the FDA approving a vaccine before the U.S. presidential election. By克里斯汀Idzelis September 10, 2020
This content is from:365亚博 Vaccines Have Arrived — And Investors Are Ready to Party Fund managers are the most bullish they’ve been all year, according to Bank of America’s monthly survey. ByAmy Whyte December 15, 2020
This content is from:www.yabo88.com JPMorgan Is Hunting for Properties in a Sector Poised for Post-Covid Growth Demand for lab space will probably rise over the long term due to the Covid-19 pandemic, says Anton Pil, global head of alternatives at J.P. Morgan Asset Management. By克里斯汀Idzelis November 24, 2020
This content is from:365亚博 A Short Seller Claims a ‘Fictional Character’ Wrote This Company’s Medical Research Gabriel Grego’s second shot at medical devices company Penumbra hits its mark. ByMichelle Celarier December 08, 2020
This content is from:亚慱体育app怎么下载 SEC Bans Former Hedge Fund Manager for Inflating Asset Prices Ex-Visium hedge fund manager Christopher Plaford also faced insider trading charges. By克里斯汀Idzelis July 30, 2019
This content is from:www.yabo88.com Short Sellers Hurt by Gilead’s Kite Acquisition Kite Pharma has likely been a target for bearish bets because the cancer-fighting technology it uses — CART — is new to the market, says Wedbush biotechnology analyst David Nierengarten. ByAlicia McElhaney August 28, 2017
